Trials / Conditions / Drug Hypersensitivity

Drug Hypersensitivity

22 registered clinical trials studyying Drug Hypersensitivity — 3 currently recruiting.

Status	Trial	Sponsor	Phase
Not Yet Recruiting	Establishment of a Registry for Immediate Drug Allergy NCT07390370	Yonsei University	—
Completed	Turkish Version of the Parent-Reported Drug Hypersensitivity Quality of Life Questionnaire NCT07069439	Prof. Dr. Cemil Tascıoglu Education and Research Hospital Organization	—
Recruiting	Optimizing the Diagnostic Approach to Cephalosporin Allergy Testing NCT06406114	Massachusetts General Hospital	Phase 2
Completed	An Evaluation of Healthcare Providers' Adherence to Pharmacovigilance Practices in an African Community NCT06428162	Deraya University	—
Completed	Validation of the English Version of the Drug Hypersensitivity Quality of Life Questionnaire NCT06523192	University Hospitals, Leicester	—
Completed	A Study to Assess the Hypersensitivity to TAK-880 Compared to Gammagard S/D in Blood of Children, Teenagers an NCT05269082	Takeda	—
Completed	Drug Allergy Labels After Drug Allergy Investigation NCT04827602	University Hospital, Gentofte, Copenhagen	—
Recruiting	Origin and Function of Eosinophilic Polynuclear During DRESS Syndrome NCT04330118	University Hospital, Lille	—
Completed	Cephalosporin Hypersensitivity NCT04421638	University Hospital, Montpellier	—
Completed	Drug Provocation Test (DPT) to Paracetamol NCT03771118	University Hospital, Montpellier	—
Completed	Drug Provocation Test (DPT) to Non Steroidal Anti-inflammatory Drugs (NSAID) NCT03743220	University Hospital, Montpellier	—
Completed	Allergy Testing of Patients Labeled as Penicillin Allergic NCT02983630	Albany Medical College	—
Completed	Medical Device for Drug Allergy Diagnosis NCT02839811	University Hospital, Montpellier	N/A
Completed	Optimal Doses for Drug Provocation Tests to Beta-lactams NCT02839551	University Hospital, Montpellier	N/A
Completed	Drug Challenges Without Prior Skin Testing NCT03158831	Montefiore Medical Center	Phase 1
Terminated	Negative Predictive Value of Drug Provocation Tests to Beta-lactams NCT02844712	University Hospital, Montpellier	N/A
Terminated	Management of Drug Hypersensitivity in Children NCT02031120	University Hospital, Geneva	—
Completed	Predictive Models for Betalactam Allergy NCT03076749	University Hospital, Montpellier	—
Completed	Evaluation of TNF-α Blockade Effect in Patients With Severe Cutaneous Adverse Drug Reactions NCT01276314	Chang Gung Memorial Hospital	N/A
Terminated	Treatment of Hypersensitivity Syndrome (DRESS) With Tegeline® (Human Immunoglobulin) NCT00505648	University Hospital, Rouen	Phase 3
Completed	Hypersensitivity Reaction to Vitrase (Ovine Hyaluronidase) NCT00198458	Bausch & Lomb Incorporated	Phase 1
Completed	Hypersensitivity Reaction to Vitrase (Ovine Hyaluronidase) NCT00198419	Bausch & Lomb Incorporated	Phase 1